Active substance (DCI)
- eculizumab
history (7)
-
4/24/24
SOLIRIS (eculizumab) - Myasthénie
CAV : -
3/22/23
SOLIRIS (éculizumab) - Atypical haemolytic uraemic syndrome (aHUS)
CAV : -
9/16/20
SOLIRIS
CAV : -
6/27/18
SOLIRIS (eculizumab)
-
6/26/13
SOLIRIS (eculizumab)
-
9/19/12
SOLIRIS
CAV :
-
10/24/07
SOLIRIS (eculizumab)
CAV :